Value proposition

Delivering innovation to frontline care with the FDA-cleared OtoSightTM Middle Ear Scope.

PhotoniCare was founded out of a shared passion to develop a superior solution for middle ear issues, primarily in children. With $10 billion spent annually to manage ear infections, and a documented 50% misdiagnosis rate for primary care physicians, current tools used to diagnose fluid in the middle ear fail to reliably interpret the patient’s condition. The FDA-cleared OtoSightTM Middle Ear Scope by PhotoniCare is a clinical diagnostic tool designed to eliminate subjectivity and speculation with a non-invasive and comprehensive assessment of middle ear fluid. OtoSightTM is indicated to not only visualize the presence of fluid, but also the fluid’s density, even in the presence of earwax. As a result, the simple-to-use OtoSightTM Middle Ear Scope has a 90+% reader accuracy in determining the presence or absence of fluid in the middle ear. Clinicians that have had an opportunity to use OtoSightTM consider it a game-changer. This is further demonstrated by multiple best-in-show product awards and over 20 supporting clinical publications. With OtoSightTM, PhotoniCare makes the otherwise invisible visible while effectively informing a successful treatment plan like never before.

Learn more at www.photoni.care.

Optical design, Handheld instrumentation design, and Non-invasive imaging